Jan 23, 2023 06:26AM
Jan 23, 2023 06:25AM
Jan 23, 2023 06:25AM
Jan 6, 2023 07:16AM
Jan 6, 2023 07:15AM
Jan 6, 2023 07:15AM
Aug 29, 2022 07:45AM Vaccines Global Market Set to Surpass $163.8 Billion by 2026
Dec 27, 2021 09:24AM
Nov 8, 2021 09:00AM
Oct 2, 2020 06:12AM
Oct 2, 2020 06:00AM
Aug 20, 2020 04:01PM
Aug 13, 2020 04:01PM
Jul 1, 2020 06:08AM BiondVax Pharma (BVXV) Reports Participants Complete Final Visit in M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial
Jul 1, 2020 06:00AM
Jun 30, 2020 04:01PM
Jun 12, 2020 08:00AM
Jun 10, 2020 07:04AM
Jun 10, 2020 07:00AM
May 20, 2020 06:30AM
May 4, 2020 06:30AM BiondVax Announces Upcoming Expiration of Public Warrants
Mar 24, 2020 04:01PM
Mar 19, 2020 07:15AM
Feb 5, 2020 01:04PM
Feb 5, 2020 01:00PM
Nov 18, 2019 07:31AM
Nov 18, 2019 07:15AM
Oct 7, 2019 09:15AM BiondVax Receives €4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Phase 3 Trial
Apr 30, 2018 04:05PM
Apr 11, 2018 07:45AM
Dec 5, 2017 09:07AM
Nov 20, 2017 09:04AM
Nov 20, 2017 09:00AM
Aug 14, 2017 08:00AM
Jul 20, 2017 06:31AM BiondVax Pharma (BVXV) Announces Positive Phase 2b Clinical Trial Results for Universal Flu Vaccine
Jul 20, 2017 06:30AM

325,595 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All